Global Small Molecule Targeted Therapy Market Report 2025

Item added to cart!

Published : December 2025

Pages :

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00 $3367.00

Purchase This Report Download Sample PDF

Purchase This Report

Small Molecule Targeted Therapy Global Market Report 2025

Name: Small Molecule Targeted Therapy Global Market Report 2025
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

By Type Of Therapy (Chemotherapy, Targeted Therapy, Immunotherapy); By Drug Class (Monoclonal Antibodies, Small Molecule Inhibitors, Combination Therapies); By Mechanism Of Action (Kinase Inhibitors, Proteasome Inhibitors, Aromatic Hydrocarbon Receptor (Ahr) Modulators, Cell Cycle Inhibitors); By Disease Indication (Cancer, Autoimmune Diseases, Infectious Diseases); By Route Of Administration (Oral, Intravenous, Subcutaneous); Subsegments:; By Chemotherapy (Alkylating Agents, Antimetabolites, Anti-microtubule Agents); By Targeted Therapy (Kinase Inhibitors, Proteasome Inhibitors, Aromatic Hydrocarbon Receptor (AhR) Modulators); By Immunotherapy (Immune Checkpoint Inhibitors, Cancer Vaccines, Monoclonal Antibodies) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Small Molecule Targeted Therapy Market Overview

• Small Molecule Targeted Therapy market size has reached to $70.45 billion in 2024

• Expected to grow to $110.52 billion in 2029 at a compound annual growth rate (CAGR) of 9.4%

• Growth Driver: Increasing Demand For Personalized Medicine Driving The Market Due To Advances In Genomics And Tailored Treatment Approaches

• Market Trend: Innovations in Oral Targeted Therapies for Chronic and Oncology Diseases

• North America was the largest region in 2024 and Asia-Pacific is the fastest growing region.

What Is Covered Under Small Molecule Targeted Therapy Market?

Small molecule targeted therapy consists of low-molecular-weight drugs that specifically interact with disease-related targets such as enzymes, receptors, or signaling proteins. They selectively inhibit or modulate disease pathways, allowing precise treatment with minimal impact on healthy cells.

The main therapy types of small molecule targeted therapy are chemotherapy, targeted therapy, and immunotherapy. Chemotherapy refers to the use of chemical drugs to kill rapidly dividing cells in the body. The main drug classes, including monoclonal antibodies, small molecule inhibitors, and combination therapies, act through mechanisms such as kinase inhibitors, proteasome inhibitors, aromatic hydrocarbon receptor (AHR) modulators, and cell cycle inhibitors. This therapy is applied to treat conditions such as cancer, autoimmune diseases, and infectious diseases and can be administered orally, intravenously, and subcutaneously.

Small Molecule Targeted Therapy Market Size and growth rate 2025 to 2029: Graph

What Is The Small Molecule Targeted Therapy Market Size 2025 And Growth Rate?

What Is The Small Molecule Targeted Therapy Market Growth Forecast?

The small molecule targeted therapy market size is expected to see strong growth in the next few years. It will grow to $110.52 billion in 2029 at a compound annual growth rate (CAGR) of 9.4%. The growth in the forecast period can be attributed to increasing prevalence of chronic and genetic diseases, rising adoption of personalized medicine, growing investment in pharmaceutical research and development, increasing awareness among healthcare professionals and patients, and rising government support and funding. Major trends in the forecast period include technology advancements in drug design, advancements in high-throughput screening techniques, developments in precision medicine platforms, technology-driven improvements in drug delivery systems, and integration of genomics and proteomics data.

Book your 30 minutes free consultation with our research experts

What’s The Trade War Impact On Pharmaceuticals Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.

How the Small Molecule Targeted Therapy Market Segmented?

1) By Type Of Therapy: Chemotherapy, Targeted Therapy, Immunotherapy

2) By Drug Class: Monoclonal Antibodies, Small Molecule Inhibitors, Combination Therapies

3) By Mechanism Of Action: Kinase Inhibitors, Proteasome Inhibitors, Aromatic Hydrocarbon Receptor (Ahr) Modulators, Cell Cycle Inhibitors

4) By Disease Indication: Cancer, Autoimmune Diseases, Infectious Diseases

5) By Route Of Administration: Oral, Intravenous, Subcutaneous

Subsegments:

1) By Chemotherapy: Alkylating Agents, Antimetabolites, Anti-microtubule Agents

2) By Targeted Therapy: Kinase Inhibitors, Proteasome Inhibitors, Aromatic Hydrocarbon Receptor (AhR) Modulators

3) By Immunotherapy: Immune Checkpoint Inhibitors, Cancer Vaccines, Monoclonal Antibodies

What Is Driving The Small Molecule Targeted Therapy Market? Increasing Demand For Personalized Medicine Driving The Market Due To Advances In Genomics And Tailored Treatment Approaches

The growing emphasis on personalized medicine is expected to propel the growth of the small molecule targeted therapy market going forward. Personalized medicine refers to a healthcare approach that tailors prevention, diagnosis, and treatment to an individual’s genetic, environmental, and lifestyle factors. Increasing personalized medicine is driven by advances in genomics, allowing deeper understanding of individual genetic variations and enabling more precise, targeted treatments that improve patient outcomes and reduce trial-and-error in therapies. Small molecule targeted therapy enables personalized medicine by selectively targeting a patient’s specific molecular or genetic disease profile, improving treatment efficacy and reducing side effects. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based non-profit organization, in 2023, the FDA approved 16 new personalized treatments for rare disease patients, up from six in 2022. The newly approved personalized treatments for 2023 also include seven cancer drugs and three for other diseases and conditions. Therefore, the growing emphasis on personalized medicine is driving the growth of the small molecule targeted therapy industry.

Who Are The Major Players In The Global Small Molecule Targeted Therapy Market?

Major companies operating in the small molecule targeted therapy market are F. Hoffmann-La Roche AG (Roche), Merck KGaA, Pfizer Inc., Bayer AG, Sanofi S.A., Novartis International AG, AstraZeneca PLC, Bristol-Myers Squibb Company, GlaxoSmithKline plc (GSK), Eli Lilly and Company, Amgen Inc., Regeneron Pharmaceuticals Inc., Astellas Pharma Inc., Lonza Group AG, Blueprint Medicines Corporation, Kura Oncology Inc., G1 Therapeutics Inc., Ascentage Pharma Group International Inc., Rgenta Therapeutics Inc., Verastem Inc.

What Are The Key Trends Of The Global Small Molecule Targeted Therapy Market? Innovations in Oral Targeted Therapies for Chronic and Oncology Diseases

Major companies operating in the small molecule targeted therapy market are focusing on developing innovative solutions such as oral small molecules to improve targeted delivery, enhance patient compliance, and address specific molecular pathways in oncology and other chronic diseases. Oral small molecule refers to a low-molecular-weight drug that can be taken by mouth and is designed to enter cells easily to specifically target disease-related proteins or pathways. For instance, in June 2025, Kura Oncology Inc., a US-based biotech company, received an FDA approval for a New Drug Application (NDA) for ziftomenib as a treatment for adult patients with relapsed or refractory acute myeloid leukemia (AML) with nucleophosmin 1 (NPM1) mutations. It is an oral targeted therapy designed for adult patients with relapsed or refractory AML carrying NPM1 mutations, addressing a critical unmet medical need. It offers a favorable safety profile and has demonstrated promising efficacy, including significant complete remission rates in clinical trials. By selectively inhibiting the menin-KMT2A interaction, ziftomenib disrupts leukemic cell growth and supports new treatment options for this hard-to-treat AML subtype.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Small Molecule Targeted Therapy Market? Wearable Smart Rings Monitor Health And Wellness Metrics

In May 2025, Eli Lilly and Company, a US-based pharmaceutical company, acquired SiteOne Therapeutics Inc. for an undisclosed amount. With this acquisition Eli Lilly and Company aims to strengthen its pain treatment portfolio by developing innovative, non-addictive therapies targeting chronic pain through advanced sodium channel inhibitors. SiteOne Therapeutics Inc. is a US-based pharmaceutical company that offers small molecule targeted therapy.

What Is The Regional Outlook For The Global Small Molecule Targeted Therapy Market?

North America was the largest region in the small molecule targeted therapy market in 2024. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Small Molecule Targeted Therapy Market?

The small molecule targeted therapy market consists of sales of tyrosine kinase inhibitors, proteasome inhibitors, and BCL-2 inhibitors. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Small Molecule Targeted Therapy Industry?

The small molecule targeted therapy market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the small molecule targeted therapy industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abhilash Pyata

1. Executive Summary

2. Small Molecule Targeted Therapy Market Characteristics

3. Small Molecule Targeted Therapy Market Trends And Strategies

4. Small Molecule Targeted Therapy Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Small Molecule Targeted Therapy Growth Analysis And Strategic Analysis Framework

5.1. Global Small Molecule Targeted Therapy PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Small Molecule Targeted Therapy Market Growth Rate Analysis

5.4. Global Small Molecule Targeted Therapy Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Small Molecule Targeted Therapy Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Small Molecule Targeted Therapy Total Addressable Market (TAM)

6. Small Molecule Targeted Therapy Market Segmentation

6.1. Global Small Molecule Targeted Therapy Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Chemotherapy

Targeted Therapy

Immunotherapy

6.2. Global Small Molecule Targeted Therapy Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Monoclonal Antibodies

Small Molecule Inhibitors

Combination Therapies

6.3. Global Small Molecule Targeted Therapy Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Kinase Inhibitors

Proteasome Inhibitors

Aromatic Hydrocarbon Receptor (Ahr) Modulators

Cell Cycle Inhibitors

6.4. Global Small Molecule Targeted Therapy Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Cancer

Autoimmune Diseases

Infectious Diseases

6.5. Global Small Molecule Targeted Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Oral

Intravenous

Subcutaneous

6.6. Global Small Molecule Targeted Therapy Market, Sub-Segmentation Of Chemotherapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Alkylating Agents

Antimetabolites

Anti-microtubule Agents

6.7. Global Small Molecule Targeted Therapy Market, Sub-Segmentation Of Targeted Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Kinase Inhibitors

Proteasome Inhibitors

Aromatic Hydrocarbon Receptor (AhR) Modulators

6.8. Global Small Molecule Targeted Therapy Market, Sub-Segmentation Of Immunotherapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Immune Checkpoint Inhibitors

Cancer Vaccines

Monoclonal Antibodies

7. Small Molecule Targeted Therapy Market Regional And Country Analysis

7.1. Global Small Molecule Targeted Therapy Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Small Molecule Targeted Therapy Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Small Molecule Targeted Therapy Market

8.1. Asia-Pacific Small Molecule Targeted Therapy Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Small Molecule Targeted Therapy Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Small Molecule Targeted Therapy Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Small Molecule Targeted Therapy Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Small Molecule Targeted Therapy Market

9.1. China Small Molecule Targeted Therapy Market Overview

9.2. China Small Molecule Targeted Therapy Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Small Molecule Targeted Therapy Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Small Molecule Targeted Therapy Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Small Molecule Targeted Therapy Market

10.1. India Small Molecule Targeted Therapy Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Small Molecule Targeted Therapy Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Small Molecule Targeted Therapy Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Small Molecule Targeted Therapy Market

11.1. Japan Small Molecule Targeted Therapy Market Overview

11.2. Japan Small Molecule Targeted Therapy Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Small Molecule Targeted Therapy Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Small Molecule Targeted Therapy Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Small Molecule Targeted Therapy Market

12.1. Australia Small Molecule Targeted Therapy Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Small Molecule Targeted Therapy Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Small Molecule Targeted Therapy Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Small Molecule Targeted Therapy Market

13.1. Indonesia Small Molecule Targeted Therapy Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Small Molecule Targeted Therapy Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Small Molecule Targeted Therapy Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Small Molecule Targeted Therapy Market

14.1. South Korea Small Molecule Targeted Therapy Market Overview

14.2. South Korea Small Molecule Targeted Therapy Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Small Molecule Targeted Therapy Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Small Molecule Targeted Therapy Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Small Molecule Targeted Therapy Market

15.1. Western Europe Small Molecule Targeted Therapy Market Overview

15.2. Western Europe Small Molecule Targeted Therapy Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Small Molecule Targeted Therapy Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Small Molecule Targeted Therapy Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Small Molecule Targeted Therapy Market

16.1. UK Small Molecule Targeted Therapy Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Small Molecule Targeted Therapy Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Small Molecule Targeted Therapy Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Small Molecule Targeted Therapy Market

17.1. Germany Small Molecule Targeted Therapy Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Small Molecule Targeted Therapy Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Small Molecule Targeted Therapy Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Small Molecule Targeted Therapy Market

18.1. France Small Molecule Targeted Therapy Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Small Molecule Targeted Therapy Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Small Molecule Targeted Therapy Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Small Molecule Targeted Therapy Market

19.1. Italy Small Molecule Targeted Therapy Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Small Molecule Targeted Therapy Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Small Molecule Targeted Therapy Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Small Molecule Targeted Therapy Market

20.1. Spain Small Molecule Targeted Therapy Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Small Molecule Targeted Therapy Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Small Molecule Targeted Therapy Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Small Molecule Targeted Therapy Market

21.1. Eastern Europe Small Molecule Targeted Therapy Market Overview

21.2. Eastern Europe Small Molecule Targeted Therapy Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Small Molecule Targeted Therapy Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Small Molecule Targeted Therapy Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Small Molecule Targeted Therapy Market

22.1. Russia Small Molecule Targeted Therapy Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Small Molecule Targeted Therapy Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Small Molecule Targeted Therapy Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Small Molecule Targeted Therapy Market

23.1. North America Small Molecule Targeted Therapy Market Overview

23.2. North America Small Molecule Targeted Therapy Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Small Molecule Targeted Therapy Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Small Molecule Targeted Therapy Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Small Molecule Targeted Therapy Market

24.1. USA Small Molecule Targeted Therapy Market Overview

24.2. USA Small Molecule Targeted Therapy Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Small Molecule Targeted Therapy Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Small Molecule Targeted Therapy Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Small Molecule Targeted Therapy Market

25.1. Canada Small Molecule Targeted Therapy Market Overview

25.2. Canada Small Molecule Targeted Therapy Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Small Molecule Targeted Therapy Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Small Molecule Targeted Therapy Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Small Molecule Targeted Therapy Market

26.1. South America Small Molecule Targeted Therapy Market Overview

26.2. South America Small Molecule Targeted Therapy Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Small Molecule Targeted Therapy Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Small Molecule Targeted Therapy Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Small Molecule Targeted Therapy Market

27.1. Brazil Small Molecule Targeted Therapy Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Small Molecule Targeted Therapy Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Small Molecule Targeted Therapy Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Small Molecule Targeted Therapy Market

28.1. Middle East Small Molecule Targeted Therapy Market Overview

28.2. Middle East Small Molecule Targeted Therapy Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Small Molecule Targeted Therapy Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Small Molecule Targeted Therapy Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Small Molecule Targeted Therapy Market

29.1. Africa Small Molecule Targeted Therapy Market Overview

29.2. Africa Small Molecule Targeted Therapy Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Small Molecule Targeted Therapy Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Small Molecule Targeted Therapy Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Small Molecule Targeted Therapy Market Competitive Landscape And Company Profiles

30.1. Small Molecule Targeted Therapy Market Competitive Landscape

30.2. Small Molecule Targeted Therapy Market Company Profiles

30.2.1. F. Hoffmann-La Roche AG (Roche) Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Bayer AG Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis

31. Small Molecule Targeted Therapy Market Other Major And Innovative Companies

31.1. Novartis International AG

31.2. AstraZeneca PLC

31.3. Bristol-Myers Squibb Company

31.4. GlaxoSmithKline plc (GSK)

31.5. Eli Lilly and Company

31.6. Amgen Inc.

31.7. Regeneron Pharmaceuticals Inc.

31.8. Astellas Pharma Inc.

31.9. Lonza Group AG

31.10. Blueprint Medicines Corporation

31.11. Kura Oncology Inc.

31.12. G1 Therapeutics Inc.

31.13. Ascentage Pharma Group International Inc.

31.14. Rgenta Therapeutics Inc.

31.15. Verastem Inc.

32. Global Small Molecule Targeted Therapy Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Small Molecule Targeted Therapy Market

34. Recent Developments In The Small Molecule Targeted Therapy Market

35. Small Molecule Targeted Therapy Market High Potential Countries, Segments and Strategies

35.1 Small Molecule Targeted Therapy Market In 2029 - Countries Offering Most New Opportunities

35.2 Small Molecule Targeted Therapy Market In 2029 - Segments Offering Most New Opportunities

35.3 Small Molecule Targeted Therapy Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Billion

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Table 3: Global Small Molecule Targeted Therapy Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 4: Global Small Molecule Targeted Therapy Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 5: Global Small Molecule Targeted Therapy Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 6: Global Small Molecule Targeted Therapy Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 7: Global Small Molecule Targeted Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 8: Global Small Molecule Targeted Therapy Market, Sub-Segmentation Of Chemotherapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 9: Global Small Molecule Targeted Therapy Market, Sub-Segmentation Of Targeted Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 10: Global Small Molecule Targeted Therapy Market, Sub-Segmentation Of Immunotherapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 11: Global Small Molecule Targeted Therapy Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 12: Global Small Molecule Targeted Therapy Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 13: Asia-Pacific, Small Molecule Targeted Therapy Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 14: Asia-Pacific, Small Molecule Targeted Therapy Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 15: Asia-Pacific, Small Molecule Targeted Therapy Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 16: China, Small Molecule Targeted Therapy Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 17: China, Small Molecule Targeted Therapy Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 18: China, Small Molecule Targeted Therapy Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 19: India, Small Molecule Targeted Therapy Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 20: India, Small Molecule Targeted Therapy Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 21: India, Small Molecule Targeted Therapy Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 22: Japan, Small Molecule Targeted Therapy Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 23: Japan, Small Molecule Targeted Therapy Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 24: Japan, Small Molecule Targeted Therapy Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 25: Australia, Small Molecule Targeted Therapy Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 26: Australia, Small Molecule Targeted Therapy Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 27: Australia, Small Molecule Targeted Therapy Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 28: Indonesia, Small Molecule Targeted Therapy Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 29: Indonesia, Small Molecule Targeted Therapy Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 30: Indonesia, Small Molecule Targeted Therapy Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 31: South Korea, Small Molecule Targeted Therapy Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 32: South Korea, Small Molecule Targeted Therapy Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 33: South Korea, Small Molecule Targeted Therapy Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 34: Western Europe, Small Molecule Targeted Therapy Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 35: Western Europe, Small Molecule Targeted Therapy Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 36: Western Europe, Small Molecule Targeted Therapy Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 37: UK, Small Molecule Targeted Therapy Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 38: UK, Small Molecule Targeted Therapy Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 39: UK, Small Molecule Targeted Therapy Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 40: Germany, Small Molecule Targeted Therapy Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 41: Germany, Small Molecule Targeted Therapy Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 42: Germany, Small Molecule Targeted Therapy Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 43: France, Small Molecule Targeted Therapy Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 44: France, Small Molecule Targeted Therapy Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 45: France, Small Molecule Targeted Therapy Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 46: Italy, Small Molecule Targeted Therapy Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 47: Italy, Small Molecule Targeted Therapy Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 48: Italy, Small Molecule Targeted Therapy Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 49: Spain, Small Molecule Targeted Therapy Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 50: Spain, Small Molecule Targeted Therapy Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 51: Spain, Small Molecule Targeted Therapy Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 52: Eastern Europe, Small Molecule Targeted Therapy Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 53: Eastern Europe, Small Molecule Targeted Therapy Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 54: Eastern Europe, Small Molecule Targeted Therapy Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 55: Russia, Small Molecule Targeted Therapy Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 56: Russia, Small Molecule Targeted Therapy Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 57: Russia, Small Molecule Targeted Therapy Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 58: North America, Small Molecule Targeted Therapy Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 59: North America, Small Molecule Targeted Therapy Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 60: North America, Small Molecule Targeted Therapy Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 61: USA, Small Molecule Targeted Therapy Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 62: USA, Small Molecule Targeted Therapy Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 63: USA, Small Molecule Targeted Therapy Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 64: Canada, Small Molecule Targeted Therapy Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 65: Canada, Small Molecule Targeted Therapy Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 66: Canada, Small Molecule Targeted Therapy Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 67: South America, Small Molecule Targeted Therapy Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 68: South America, Small Molecule Targeted Therapy Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 69: South America, Small Molecule Targeted Therapy Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 70: Brazil, Small Molecule Targeted Therapy Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 71: Brazil, Small Molecule Targeted Therapy Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 72: Brazil, Small Molecule Targeted Therapy Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 73: Middle East, Small Molecule Targeted Therapy Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 74: Middle East, Small Molecule Targeted Therapy Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 75: Middle East, Small Molecule Targeted Therapy Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 76: Africa, Small Molecule Targeted Therapy Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 77: Africa, Small Molecule Targeted Therapy Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 78: Africa, Small Molecule Targeted Therapy Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 79: F. Hoffmann-La Roche AG (Roche) Financial Performance

Table 80: Merck KGaA Financial Performance

Table 81: Pfizer Inc. Financial Performance

Table 82: Bayer AG Financial Performance

Table 83: Sanofi S.A. Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Billion

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Figure 3: Global Small Molecule Targeted Therapy Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 4: Global Small Molecule Targeted Therapy Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 5: Global Small Molecule Targeted Therapy Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 6: Global Small Molecule Targeted Therapy Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 7: Global Small Molecule Targeted Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 8: Global Small Molecule Targeted Therapy Market, Sub-Segmentation Of Chemotherapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 9: Global Small Molecule Targeted Therapy Market, Sub-Segmentation Of Targeted Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 10: Global Small Molecule Targeted Therapy Market, Sub-Segmentation Of Immunotherapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 11: Global Small Molecule Targeted Therapy Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 12: Global Small Molecule Targeted Therapy Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 13: Asia-Pacific, Small Molecule Targeted Therapy Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 14: Asia-Pacific, Small Molecule Targeted Therapy Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 15: Asia-Pacific, Small Molecule Targeted Therapy Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 16: China, Small Molecule Targeted Therapy Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 17: China, Small Molecule Targeted Therapy Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 18: China, Small Molecule Targeted Therapy Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 19: India, Small Molecule Targeted Therapy Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 20: India, Small Molecule Targeted Therapy Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 21: India, Small Molecule Targeted Therapy Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 22: Japan, Small Molecule Targeted Therapy Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 23: Japan, Small Molecule Targeted Therapy Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 24: Japan, Small Molecule Targeted Therapy Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 25: Australia, Small Molecule Targeted Therapy Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 26: Australia, Small Molecule Targeted Therapy Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 27: Australia, Small Molecule Targeted Therapy Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 28: Indonesia, Small Molecule Targeted Therapy Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 29: Indonesia, Small Molecule Targeted Therapy Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 30: Indonesia, Small Molecule Targeted Therapy Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 31: South Korea, Small Molecule Targeted Therapy Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 32: South Korea, Small Molecule Targeted Therapy Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 33: South Korea, Small Molecule Targeted Therapy Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 34: Western Europe, Small Molecule Targeted Therapy Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 35: Western Europe, Small Molecule Targeted Therapy Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 36: Western Europe, Small Molecule Targeted Therapy Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 37: UK, Small Molecule Targeted Therapy Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 38: UK, Small Molecule Targeted Therapy Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 39: UK, Small Molecule Targeted Therapy Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 40: Germany, Small Molecule Targeted Therapy Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 41: Germany, Small Molecule Targeted Therapy Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 42: Germany, Small Molecule Targeted Therapy Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 43: France, Small Molecule Targeted Therapy Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 44: France, Small Molecule Targeted Therapy Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 45: France, Small Molecule Targeted Therapy Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 46: Italy, Small Molecule Targeted Therapy Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 47: Italy, Small Molecule Targeted Therapy Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 48: Italy, Small Molecule Targeted Therapy Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 49: Spain, Small Molecule Targeted Therapy Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 50: Spain, Small Molecule Targeted Therapy Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 51: Spain, Small Molecule Targeted Therapy Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 52: Eastern Europe, Small Molecule Targeted Therapy Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 53: Eastern Europe, Small Molecule Targeted Therapy Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 54: Eastern Europe, Small Molecule Targeted Therapy Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 55: Russia, Small Molecule Targeted Therapy Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 56: Russia, Small Molecule Targeted Therapy Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 57: Russia, Small Molecule Targeted Therapy Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 58: North America, Small Molecule Targeted Therapy Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 59: North America, Small Molecule Targeted Therapy Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 60: North America, Small Molecule Targeted Therapy Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 61: USA, Small Molecule Targeted Therapy Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 62: USA, Small Molecule Targeted Therapy Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 63: USA, Small Molecule Targeted Therapy Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 64: Canada, Small Molecule Targeted Therapy Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 65: Canada, Small Molecule Targeted Therapy Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 66: Canada, Small Molecule Targeted Therapy Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 67: South America, Small Molecule Targeted Therapy Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 68: South America, Small Molecule Targeted Therapy Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 69: South America, Small Molecule Targeted Therapy Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 70: Brazil, Small Molecule Targeted Therapy Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 71: Brazil, Small Molecule Targeted Therapy Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 72: Brazil, Small Molecule Targeted Therapy Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 73: Middle East, Small Molecule Targeted Therapy Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 74: Middle East, Small Molecule Targeted Therapy Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 75: Middle East, Small Molecule Targeted Therapy Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 76: Africa, Small Molecule Targeted Therapy Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 77: Africa, Small Molecule Targeted Therapy Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 78: Africa, Small Molecule Targeted Therapy Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 79: F. Hoffmann-La Roche AG (Roche) Financial Performance

Figure 80: Merck KGaA Financial Performance

Figure 81: Pfizer Inc. Financial Performance

Figure 82: Bayer AG Financial Performance

Figure 83: Sanofi S.A. Financial Performance

Global Complete Nutrition Products Market Landscape: Trends and Market Share to 2029

Competitive and Market Trend Analysis of Conjugate Vaccine Industry Through 2029

Industry Trends Show Cosmeceuticals Market Set to Expand at 8.8% CAGR Until 2029

Strategic Report on Cosmetic Ingredients Market: Growth Opportunities and Emerging Challenges

A 2025 analysis offering size estimates, growth trends and technological innovations in the live cell imaging microscopes market.

Discover key trends and market dynamics in the Mycobacterium Tuberculosis Market with 2025 insights from The Business Research Company.

Discover key trends and market dynamics in the Smoking Cessation & Nicotine De-addiction Products Market with 2025 insights from The Business Research Company.

Discover key trends and market dynamics in the MSI-H and DMMR Market with 2025 insights from The Business Research Company.

Targeted Therapy Global Market Report 2025 – By Type (Small Molecule Medicines, Monoclonal Antibodies), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Application (Breast Cancer, ...

RNA Targeting Small Molecules Therapeutics Global Market Report 2025 – By Offering (mRNA (Messenger Ribonucleic Acid) Translation Modulators, RNA (Ribonucleic Acid) Splicing Modification, Direct RNA (Ribonucleic Acid) Ta...

RNA Targeting Small Molecule Drug Discovery Global Market Report 2025 – By Target RNA Type (Messenger RNA (mRNA), Non-Coding RNA (ncRNA), MicroRNA (miRNA), Long Non-Coding RNA (lncRNA)), By Technology (CRISPR-Cas9, RNA A...

Small Molecule Injectable Drugs Global Market Report 2025 – By Drug Class (Small Molecule Antibiotics, Analgesics, Chemotherapy, Antivirals, Anticoagulant, Skeletal Muscle Relaxants, Anticonvulsants, Other Drug Class), B...

Small Molecule Active Pharmaceutical Ingredient Global Market Report 2025 – By Type (Synthetic, Chemical, Biological), By Therapeutic Type (Autoimmune Diseases, Oncology, Metabolic Diseases, Ophthalmology, Cardiovascular...

Small Cell Lung Cancer Therapeutics Global Market Report 2025 – By Drug Type (Atezolizumab, Topotecan, Lurbinectedin, Durvalumab, Methotrexate, Pembrolizumab), By Treatment Type (Chemotherapy, Targeted Therapy, Other Tre...

Non-Small Cell Lung Cancer (NSCLC) Global Market Report 2025 – By Type (Squamous Cell Carcinoma, Large Cell Carcinoma, Adenocarcinoma, Other Types), By Therapy (Radiotherapy, Laserthearpy, Photodynamic Therapy (PDT), Oth...

Frequently Asked Questions

What is the definition of the Small Molecule Targeted Therapy market?

How will the Small Molecule Targeted Therapy market drivers and restraints affect the market dynamics? What forces will shape the Small Molecule Targeted Therapy industry going forward?

The market major growth driver - Increasing Demand For Personalized Medicine Driving The Market Due To Advances In Genomics And Tailored Treatment Approaches. For further insights on this market, request a sample here

What is the forecast market size or the forecast market value of the Small Molecule Targeted Therapy market?

The small molecule targeted therapy market size has grown strongly in recent years. It will grow from $70.45 billion in 2024 to $77.29 billion in 2025 at a compound annual growth rate (CAGR) of 9.7%. The growth in the historic period can be attributed to growing availability of advanced diagnostic tools, increasing number of clinical trials, rising focus on oncology and rare disease treatments, increasing regulatory approvals for innovative small molecule drugs, and growing emphasis on combination therapies. The small molecule targeted therapy market size is expected to see strong growth in the next few years. It will grow to $110.52 billion in 2029 at a compound annual growth rate (CAGR) of 9.4%. The growth in the forecast period can be attributed to increasing prevalence of chronic and genetic diseases, rising adoption of personalized medicine, growing investment in pharmaceutical research and development, increasing awareness among healthcare professionals and patients, and rising government support and funding. Major trends in the forecast period include technology advancements in drug design, advancements in high-throughput screening techniques, developments in precision medicine platforms, technology-driven improvements in drug delivery systems, and integration of genomics and proteomics data. For further insights on this market, request a sample here

How is the Small Molecule Targeted Therapy market segmented?

The small molecule targeted therapy market covered in this report is segmented as
1) By Type Of Therapy: Chemotherapy, Targeted Therapy, Immunotherapy
2) By Drug Class: Monoclonal Antibodies, Small Molecule Inhibitors, Combination Therapies
3) By Mechanism Of Action: Kinase Inhibitors, Proteasome Inhibitors, Aromatic Hydrocarbon Receptor (Ahr) Modulators, Cell Cycle Inhibitors
4) By Disease Indication: Cancer, Autoimmune Diseases, Infectious Diseases
5) By Route Of Administration: Oral, Intravenous, Subcutaneous Subsegments:
1) By Chemotherapy: Alkylating Agents, Antimetabolites, Anti-microtubule Agents
2) By Targeted Therapy: Kinase Inhibitors, Proteasome Inhibitors, Aromatic Hydrocarbon Receptor (AhR) Modulators
3) By Immunotherapy: Immune Checkpoint Inhibitors, Cancer Vaccines, Monoclonal Antibodies For further insights on this market, request a sample here

Which region has the largest share of the Small Molecule Targeted Therapy market? What are the other regions covered in the report?

North America was the largest region in the small molecule targeted therapy market in 2024. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in small molecule targeted therapy report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. For further insights on this market, request a sample here.

Who are the major players in the Small Molecule Targeted Therapy market?

What are the key trends in the Small Molecule Targeted Therapy market?

Major trends in this market include Innovations in Oral Targeted Therapies for Chronic and Oncology Diseases For further insights on this market, request a sample here.